ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

IMUX Company Profile and Key Details

NASDAQ : IMUX

Immunic, Inc.

$0.98

0.0375+3.98%

At Close 4:00 PM

66.98

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Immunic, Inc. (IMUX) stock surged +3.98%, trading at $0.98 on NASDAQ, up from the previous close of $0.94. The stock opened at $0.94, fluctuating between $0.95 and $0.98 in the recent session.

Stock Snapshot

0.9425

Prev. Close

0.94

Open

93.9M

Market Cap

95.82M

Number of Shares

0.9486

Day Low

0.98

Day High

-0.98

P/E Ratio

92.47%

Free Float in %

-1

EPS (TTM)

0.65

Book Value

-1.59

Cash Flow per Share

214.65K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 17, 2025	0.94	0.99	0.94	0.98	214.65K
Apr 16, 2025	1.00	1.01	0.93	0.94	381.89K
Apr 15, 2025	0.91	1.00	0.91	0.99	435.29K
Apr 14, 2025	0.91	0.97	0.90	0.92	381.94K
Apr 11, 2025	0.89	0.94	0.86	0.90	540.7K
Apr 10, 2025	0.99	0.99	0.86	0.88	560.32K
Apr 09, 2025	0.91	0.96	0.83	0.92	1.04M
Apr 08, 2025	0.99	1.03	0.88	0.90	800.92K
Apr 07, 2025	0.98	0.98	0.90	0.94	767.64K
Apr 04, 2025	1.02	1.06	0.99	1.00	713.01K
Apr 03, 2025	1.07	1.09	1.03	1.05	844.01K
Apr 02, 2025	1.05	1.15	1.02	1.12	724.07K
Apr 01, 2025	1.12	1.14	1.06	1.07	757.61K
Mar 31, 2025	1.18	1.18	1.08	1.09	1.1M
Mar 28, 2025	1.28	1.28	1.18	1.20	651.19K
Mar 27, 2025	1.20	1.26	1.19	1.24	591.06K
Mar 26, 2025	1.25	1.26	1.18	1.20	667.9K
Mar 25, 2025	1.19	1.35	1.19	1.25	1.15M
Mar 24, 2025	1.16	1.18	1.15	1.17	575.34K
Mar 21, 2025	1.13	1.16	1.12	1.15	270.6K

Contact Details

New York, NY 10036

United States

Website: https://www.immunic-therapeutics.comContact: 332 255 9818

About Company

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.

Frequently Asked Questions

What is the current Immunic, Inc. (IMUX) stock price?

Immunic, Inc. (NASDAQ: IMUX) stock price is $0.98 in the last trading session. During the trading session, IMUX stock reached the peak price of $0.98 while $0.95 was the lowest point it dropped to. The percentage change in IMUX stock occurred in the recent session was 3.98% while the dollar amount for the price change in IMUX stock was $0.04.

IMUX's industry and sector of operation?

The NASDAQ listed IMUX is part of Biotechnology industry that operates in the broader Healthcare sector. Immunic, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IMUX?

Dr. Duane D. Nash M.B.A., M.D., J.D., M.B.A
Executive Chairman
Mr. Glenn Whaley CPA
Chief Financial Officer
Mr. Inderpal Singh
Gen. Counsel
Dr. Hella Kohlhof
Chief Scientific Officer
Mr. Patrick Walsh
Chief Bus. Officer
Dr. Daniel Vitt
Chief Executive Officer, Pres & Director
Jessica Breu
Head of Investor Relations & Communications
Dr. Andreas Muehler M.D., Ph.D.
Chief Medical Officer
Dr. Daniel Vitt Ph.D.
Chief Executive Officer, Pres & Director
Dr. Duane D. Nash J.D., M.B.A, M.B.A., M.D.
Executive Chairman

How IMUX did perform over past 52-week?

IMUX's closing price is 17.79% higher than its 52-week low of $0.83 where as its distance from 52-week high of $2.11 is -53.55%.

How many employees does IMUX have?

Number of IMUX employees currently stands at 85.

Link for IMUX official website?

Official Website of IMUX is: https://www.immunic-therapeutics.com

How do I contact IMUX?

IMUX could be contacted at phone 332 255 9818 and can also be accessed through its website. IMUX operates from 1200 Avenue of the Americas, New York, NY 10036, United States.

How many shares of IMUX are traded daily?

IMUX stock volume for the day was 214.65K shares. The average number of IMUX shares traded daily for last 3 months was 790.74K.

What is the market cap of IMUX currently?

The market value of IMUX currently stands at $93.90M with its latest stock price at $0.98 and 95.82M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	85
Beta	1.9
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology